Change search
ReferencesLink to record
Permanent link

Direct link
Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer
Show others and affiliations
2011 (English)In: Cancer Epidemiology, Biomarkers and Prevention, ISSN 1055-9965, E-ISSN 1538-7755, Vol. 20, no 12, 2541-2550 p.Article in journal (Refereed) Published
Abstract [en]

Background: Several sexually transmitted infections (STI) have been reported to interact with human papillomavirus (HPV) in the etiology of cervical cancer. A large cohort study is required to obtain a both unbiased and stable estimate of their effects.

Methods: Four major biobanks in the Nordic Countries containing samples from about 1,000,000 subjects were linked with nation-wide cancer registries. Serum samples from 604 women with invasive cervical cancer (ICC) diagnosed on average 10 years after sampling and 2,980 matched control women were retrieved and analyzed with serology for key STI.

Results: Exposure to HPV16 was the strongest risk factor for cervical cancer [ OR = 2.4; 95% confidence interval (CI), 2.0-3.0], particularly for squamous cell carcinoma (OR = 2.9; 95% CI, 2.2-3.7). HPV18 was strongly associated with increased risk for adenocarcinoma (OR = 2.3; 95% CI, 1.3-4.1). Baseline seropositivity for HPV16 did not confer any increased risk for HPV18 DNA-positive cancer and conversely HPV18 seropositivity had no association with HPV16 DNA-positive cancers. HPV6 had no effect on its own (OR = 1.1; 95% CI, 0.9-1.3), but had an antagonistic effect on the risk conferred by HPV16 (P < 0.01). Herpes simplex virus 2 had little or no association (OR = 1.1; 95% CI, 0.8-1.4). Previous exposure to Chlamydia trachomatis, as indicated by serum antibodies, had a strongly increased risk for cervical cancer (OR = 1.9; 95% CI, 1.5-2.3).

Conclusions: A large prospective study has assessed the role of different STIs in cervical cancer.

Impact: Prospective evidence supports cofactor role of some STI in cervical cancer.

Cancer Epidemiol Biomarkers Prev; 20(12); 2541-50. (C) 2011 AACR.

Place, publisher, year, edition, pages
2011. Vol. 20, no 12, 2541-2550 p.
Keyword [en]
herpes-simplex-virus; chlamydia-trachomatis infection; squamous-cell carcinoma; nested case-control; serum antibodies; intraepithelial neoplasia; multiple types; hpv type; women; adenocarcinoma
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-51486DOI: 10.1158/1055-9965.EPI-11-0761ISI: 000298234900010OAI: diva2:482088
Available from: 2012-01-23 Created: 2012-01-23 Last updated: 2012-01-23Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Wadell, Göran
By organisation
In the same journal
Cancer Epidemiology, Biomarkers and Prevention
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 43 hits
ReferencesLink to record
Permanent link

Direct link